ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #501Top JournalGold OA

Journal of Neuroinflammation

Abbreviation (ISO):J NEUROINFLAMM
•
Identifier (ISSN):1742-2094(Print)
•
Publisher:BioMed Central
Clarivate IF (2026)
11.5↑ +1.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Neuroinflammation

WoS Q1
3711155.1920185.720195.7920208.3220219.5920229.320239.3202410.1202511.52026
Annual Impact Factor Metric
Current (2026):11.5
Scopus SJR & RankScopus Q1
3.685
#501

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
189

189 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate3.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
303articles/year
100% Gold OA•89.94% Original Research

Aims & Scope

Journal of Neuroinflammation is an open access, peer-reviewed journal that focuses on interactions of the immune system (and especially the innate immune system) with the nervous system. This includes the roles of CNS immune mediators (such as microglia and astrocytes, and their expressed cytokines and chemokines) as well as the roles of peripheral neuro-immune interactions, T cells, monocytes, complement proteins, acute phase proteins, oxidative injury and related molecular processes. Neuroinflammation is a rapidly expanding field that has revolutionized our understanding of chronic neurological diseases. This field has grown to encompass researchers with backgrounds in many diverse fields, including pathology, biochemistry, molecular biology, genetics, clinical medicine, and epidemiology. Important contributions to this field have come from work with populations, patients, postmortem tissues, animal models, and in vitro systems. Journal of Neuroinflammation brings together work focusing on common pathogenic processes, and provides a forum for integrative reviews and commentaries on this field.

Topics Covered (Recognized by AI)
Medicine99.7%Biology99.7%Internal medicine97.8%Immunology91.3%Genetics87%Psychology80.4%Chemistry80.1%Biochemistry77.4%Inflammation75.7%Neuroscience74.3%Pathology74.3%Endocrinology64.9%Disease56.3%Psychiatry52%Microglia42.7%Receptor40.4%Cell biology40.3%Neuroinflammation40.2%Immune system35.8%Central nervous system31%Gene30.2%Pharmacology29.3%Physics24.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q1
Rank12/183
IndexSCIE
JCRSCIE2026

NEUROSCIENCES

Q1
Rank13/330
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q1
Rank9/183
IndexSCIE
JCISCIE2026

NEUROSCIENCES

Q1
Rank11/330
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF11.5
Articles / Year381
Total Citations305
2025
IF10.1
Articles / Year342
Total Citations3,495
2024
IF9.3
Articles / Year332
Total Citations7,336
2023
IF9.3
Articles / Year309
Total Citations11,494
2022
IF9.587
Articles / Year320
Total Citations18,030

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #501Scopus Q1SCImago Profile
Scopus Coverage:2004-2026
Scopus Broad Areas:Immunology and MicrobiologyNeuroscience
Scopus Citation Rank (SJR)Q1
3.685

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
11.19

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,047 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations12,017
3-Year Documents947
Citable Documents946

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate47.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cellular and Molecular NeuroscienceQ1
ImmunologyQ1
NeurologyQ1
Neuroscience (miscellaneous)Q1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Neuroinflammation (abbr: J NEUROINFLAMM, ISSN: 1742-2094) is a peer-reviewed international scholarly journal in the field of Medicine, published by BioMed Central in England since 2004. The periodical holds a Journal Impact Factor (JIF) of 11.5, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.685 (Q1), an H-index of 189.

The journal enforces rigorous peer evaluation with a publication frequency of Irregular, an annual output of approximately 303 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $4,047 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
BioMed Central
Publication Language
English
Frequency
Irregular
Founding Year
2004
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 856db72f-7713-4e75-a397-4c146dc5bc71
Database Updated: 2026-10-01